More specifically, disorders of glucose metabolism, ranging from clinically silent insulin resistance through degrees of hyperglycemia defining prediabetes and diabetes, can precipitate changes in the lung consistent with asthma through pathways principally involving insulin excess. This evidence concerns the gene INS and asthma.